🚀 Medial Secures Investment on Shark Tank India - Fueling the Future of Professional Social Networking. 🔥
Login

News on Medial

Related News

Skincare brand Be Clinical raises seed round led by V3 Ventures

EntrackrEntrackr · 1d ago
Skincare brand Be Clinical raises seed round led by V3 Ventures
Medial

Skincare brand Be Clinical raises seed round led by V3 Ventures Skincare brand Be Clinical has raised Rs 6 crore in a seed funding round led by V3 Ventures, with participation from Titan Capital, founded by Kunal Bahl and Rohit Bansal, who have doubled down on their commitment to the brand. The Mumbai-based brand had previously mopped up Rs 2 crore in the same funding round led by Titan Capital, along with participation from P-TAL founder Aditya Agarwal. The proceeds will be used for research and development to strengthen in-house formulation capabilities, conduct clinical testing, and develop targeted solutions for ageing concerns across the face, body, and scalp, Be Clinical said in a press release. Launched in May last year by Hemangi Dhir, Be Clinical is an evidence-led skincare brand offering clinically tried solutions for ageing skin, developed specifically for Indian skin and conditions. Backed by in-house research and dermatologically active ingredients, the brand addresses ageing concerns with a strong focus on transparency, education, and measurable results. Be Clinical aims to address a gap in the Indian skincare market such as the lack of science-led, transparent, and clinically validated solutions designed specifically for Indian skin and environmental conditions. The brand says that it differentiates itself through in-vivo tested, clinically validated formulations, supported by end-to-end in-house research and manufacturing and responsible formulation. Since its inception, Be Clinical claims that it has demonstrated strong early traction in a short period and served over 25,000 customers, reflecting rapid adoption and growing consumer trust in its clinically driven, India-specific skincare solutions. The company plans to expand its manufacturing facility by adding advanced machinery to improve production capacity, consistency, and quality control. The brand aspires to upgrade packaging with functional, protective, and premium formats that preserve ingredient efficacy while reinforcing the brand’s clinical-grade positioning. It competes with other notable players such as Olay, Neutrogena, Clinique, and Dr. Sheth in the anti-ageing category.

Titan Capital Winners Fund raises target corpus of Rs 200 Cr

EntrackrEntrackr · 1y ago
Titan Capital Winners Fund raises target corpus of Rs 200 Cr
Medial

Titan Capital Winners Fund, which is backed by Snapdeal co-founders Kunal Bahl and Rohit Bansal, has raised its target corpus of Rs 200 crore as the duo will anchor this fund as its largest investors. The fund will invest exclusively in follow-on rounds of breakout companies from its seed portfolio. “With the Titan Capital Winners Fund, we can more significantly support the founders of our portfolio companies in subsequent rounds of capital raises, further strengthening Titan Capital’s partnership with them,” Bahl and Bansal said in a joint press release. The Titan Capital Winners Fund focuses on tech-enabled businesses led by founders and management teams building category creators. The fundraise was completed in less than six months and the fund’s LPs include prominent family offices, CEOs and founders of leading companies, and key figures from the VC landscape. Titan Capital said that a select number of LPs are expected to be added via the optional greenshoe. In addition to Bahl and Bansal, the Winners Fund is managed by a team including Chetan Rana, who is serving as the chief financial officer (CFO). Titan Capital has backed more than 250 companies since 2011. Some of its seed investment portfolio includes Urban Company, MamaEarth, OfBusiness, Razorpay, Unicommerce, and Ola Cabs. Through the fund, Bahl and Bansal also made hefty exits from Urban Company, MamaEarth, Ola and Credgenics. For context, they had invested Rs 57 lakh total in Urban Company’s early funding rounds and recently took complete exit with Rs 111 crore. In Ola, their original investment was to the tune of $60,000 while the SoftBank-backed company reached its peak valuation of $7.3 billion in 2021 when they exited fully. E-commerce SaaS platform Unicommerce, which also comes under the umbrella of Snapdeal owner AceVector, went public. It was one of the profitable startups to get listed on the stock exchange.

Tagged as promoter of Snapdeal-backed Unicommerce eSolutions, SoftBank seeks indemnity rights from Kunal Bahl, Rohit Bansal

Money ControlMoney Control · 1y ago
Tagged as promoter of Snapdeal-backed Unicommerce eSolutions, SoftBank seeks indemnity rights from Kunal Bahl, Rohit Bansal
Medial

Market regulator SEBI has designated SoftBank as the promoter of Unicommerce eSolutions, a SaaS company backed by Snapdeal. In response, SoftBank has entered into an indemnity agreement with Snapdeal's founders, Kunal Bahl and Rohit Bansal, to protect itself and its executives from any liabilities arising from being classified as a promoter. Unicommerce has identified AceVector Limited, Starfish I Pte. Ltd (a SoftBank entity), and Kunal Bahl and Rohit Bansal as its promoters. This move reflects SEBI's increased scrutiny on promoters and promoter groups of IPO-bound companies, which has prompted more indemnity agreements between investors and founders.

Download the medial app to read full posts, comements and news.